Charlson comorbidity index

Related by string. Charlson Comorbidity Index * : Charlson . Drew Charlson / Comorbidity : National Comorbidity Survey . psychiatric comorbidity . Comorbidity Study . comorbidity / indexing . indexed . INDEX . Indexing . Indexed . indexer : Producer Price Index . Small Cap Index . Germany DAX index . Present Situation Index . Shanghai composite index . Consumer Confidence Index * *

Related by context. All words. (Click for frequent words.) 66 psychiatric comorbidities 66 BMI z 65 de novo AML 64 obstructive CAD 64 sociodemographic factors 64 HbA1C levels 64 % CI #.#-#.# [008] 64 sociodemographic characteristics 64 multivariable analysis 63 comorbidity 63 tumor histology 63 CORE OM 63 APOE genotype 63 sociodemographic variables 63 MMSE scores 63 Multivariate analysis revealed 63 preoperative PSA 63 elevated LDH 63 nondiabetic patients 63 Univariate analysis 63 postoperative mortality 63 histological subtype 62 hematopoietic cancers 62 comorbid illnesses 62 MMSE score 62 confidence intervals CIs 62 multivariate analyzes 62 tertiles 62 Charlson Comorbidity Index 62 comorbid conditions 62 % CI #.#-#.# [007] 62 nondepressed 62 #q# deletion syndrome 62 logistic regression analysis 62 CI #.#-#.# [001] 61 affective psychosis 61 histologic subtype 61 psychiatric comorbidity 61 psychiatric morbidity 61 TT genotype 61 postoperative delirium 61 LV dysfunction 61 hyper IgE syndrome 61 SGRQ 61 CHD CVD 61 postdischarge 61 colorectal adenoma 61 ELBW infants 61 HRQL 61 Uncontrolled hypertension 61 postoperative AF 61 obstructive coronary artery 61 autonomic dysfunction 60 prostate cancer CaP 60 subclinical atherosclerosis 60 preintervention 60 lowest tertile 60 echocardiographic parameters 60 multivariable analyzes 60 Cognitive impairment 60 diabetes mellitus DM 60 Breslow thickness 60 malignant neoplasm 60 perioperative mortality 60 HER2 expression 60 HIV HCV coinfected 60 depressive symptomatology 60 Operative mortality 60 biochemical recurrence 60 % CI #.#-#.# [006] 60 aortic calcification 60 BRCA1 mutation carriers 60 HOMA IR 60 NIHSS score 60 Complication rates 60 HAQ DI 60 Baseline characteristics 60 biopsy Gleason 60 CHADS2 60 EQ 5D 59 NIHSS 59 femoral neck BMD 59 % CI #.#-#.# [003] 59 noncardiac 59 multivariable adjustment 59 sociodemographic 59 CVD mortality 59 underwent coronary angiography 59 Stent thrombosis 59 socioeconomic status SES 59 pretest probability 59 MetS 59 Hb A1C 59 Hip fracture 59 multivariable adjusted 59 impaired glucose metabolism 59 mean ± SEM 59 Comorbidity 59 perioperative complications 59 nonobese 59 acetabular dysplasia 59 waist circumference WC 59 CHD mortality 59 bivariate 59 nonvertebral fracture 59 neurodevelopmental impairment 59 spirometric 59 serum PTH 59 elevated fasting glucose 59 stratifying patients 59 systolic dysfunction 59 SCr 59 neurocognitive functioning 59 C difficile infection 59 prognostic variables 59 neurologic impairment 59 inflammatory biomarkers 59 poor metabolizers 59 comorbid disorders 59 postoperative morbidity 59 p = #.# [003] 59 postoperative infections 59 inhospital mortality 59 baseline HbA1c 59 PSQI 59 troponin T 59 nonfasting triglyceride levels 59 osteopenic 59 serum IGF 59 noncardiovascular mortality 59 renal cysts 59 preoperative intraoperative 59 poststroke 59 adiponectin concentrations 59 ALT elevation 59 GH deficiency 58 urolithiasis 58 nonadherence 58 HRQoL 58 shorter telomere length 58 postoperative pulmonary 58 unfavorable cytogenetics 58 advanced adenoma 58 coexisting illnesses 58 multivessel disease 58 diastolic pressures 58 antipsychotic prescribing 58 atypical hyperplasia 58 undergoing coronary angiography 58 arterial thickening 58 Scheuermann kyphosis 58 DAS# CRP 58 confidence interval #.#-#.# 58 somatization disorder 58 Kaplan Meier estimates 58 advanced neoplasia 58 extracapsular extension 58 euthymic patients 58 medication nonadherence 58 pT3 58 = #.#-#.# 58 immune reconstitution syndrome 58 β = 58 univariate analysis 58 HRQOL 58 serum lipid levels 58 EDSS scores 58 hip BMD 58 estimated glomerular filtration 58 subclinical disease 58 nodal metastases 58 polyp recurrence 58 glycated hemoglobin levels 58 MADRS score 58 sd = 58 IPAH 58 NNT = 58 primary aldosteronism 58 socio demographic 58 HbA 1c levels 58 nonpsychiatric 58 covariate 58 attain statistical significance 58 PSADT 58 neurodevelopmental outcomes 58 somatoform disorders 58 periprocedural MI 58 atherogenic dyslipidemia 58 underwent CABG 58 hepatorenal syndrome 58 Logistic regression analysis 58 logistic regression model 58 hippocampal volumes 58 leukocyte count 58 plasma homocysteine levels 58 alanine aminotransferase ALT 58 deep venous thromboses 58 comorbidities 58 abdominal adiposity 58 Univariate 58 multivariate adjustment 58 NSTEMI 57 liver transplant recipients 57 Socioeconomic status 57 odds ratios ORs 57 MS DRG 57 acute cholecystitis 57 postoperative complication 57 gastric cardia 57 logistic regression models 57 Multivariate analyzes 57 diastolic hypertension 57 chorioamnionitis 57 glomerular filtration 57 recurrent VTE 57 venous thromboembolic disease 57 recurrent tonsillitis 57 oncologic outcomes 57 posttreatment 57 adverse cytogenetics 57 fasting triglyceride levels 57 EDSS score 57 arterial thromboembolic events 57 thyrotropin levels 57 LRTI 57 mRS 57 pCR 57 adnexal mass 57 amnestic MCI 57 comorbid depression 57 DLQI 57 hypertension diabetes mellitus 57 serum creatinine levels 57 DAS# remission 57 antiretroviral naïve 57 hypovitaminosis D 57 albumin excretion rate 57 polygenic 57 advanced adenomas 57 elevated triglyceride levels 57 clinically asymptomatic 57 HADS 57 vitamin D inadequacy 57 haematologic 57 gastric carcinoma 57 recurrent venous thromboembolism 57 systolic hypertension 57 limiting generalizability 57 renal artery stenosis 57 REYATAZ r arm 57 intraventricular hemorrhage 57 extracolonic findings 57 malabsorptive 57 clinicopathologic 57 T2DM 57 nondiabetic 57 arterial oxygen saturation 57 plasma cortisol 57 comorbid anxiety 57 Prehypertension 57 gestational diabetes mellitus GDM 57 gallstone disease 57 baseline FEV 57 del 5q 57 dose atorvastatin 57 APACHE II 57 antidiabetic medication 57 hyperhomocysteinemia 57 Myocardial infarction 57 parous women 57 neurologic complications 57 benign thyroid nodules 57 bacterial prostatitis 57 logistic regression analyzes 57 serum selenium 57 bivariate analyzes 57 nonsevere 57 multivariate logistic regression 57 ratio WHR 57 rebleeding 57 serum urate levels 57 operable breast cancer 57 nonfatal MI 57 NMIBC 57 postprocedure 57 overt nephropathy 57 System IPSS 57 CI #.#-#.# [002] 57 lymphoproliferative disorders 57 serum PSA 57 oesophageal adenocarcinoma 57 Logistic regression 57 nonalcoholic steatohepatitis 56 polyarticular 56 HIV uninfected 56 albumin excretion 56 ASCUS 56 NNRTI resistance 56 patients undergoing CABG 56 polytherapy 56 beta blocker therapy 56 subclinical hypothyroidism 56 nonfasting triglycerides 56 ANCOVA 56 glycated hemoglobin HbA1c 56 mL/min/#.# m 2 56 cranial irradiation 56 femoral neck fracture 56 serum aminotransferase levels 56 pg ml 56 pulmonary dysfunction 56 node metastases 56 B streptococcal 56 schizophreniform disorder 56 highest tertile 56 FluCAM arm 56 cerebral microbleeds 56 elevated troponin 56 hemoglobin A1c levels 56 VLBW infants 56 univariate analyzes 56 GBA mutations 56 carotid plaques 56 HER2 overexpression 56 MDRD 56 sensory neuropathy 56 carotid IMT 56 postintervention 56 psychosocial variables 56 coronary stenosis 56 NIH CPSI 56 carotid stenosis 56 BMI percentile 56 nonexposed 56 interobserver reliability 56 angiographically 56 VLBW 56 asymptomatic PAD 56 EGFR mutation positive 56 CR nPR 56 femoral neck fractures 56 allele frequencies 56 transaminase levels 56 platelet reactivity 56 definite stent thrombosis 56 cerebral oxygenation 56 hemoglobin concentrations 56 #OHD 56 radiographic findings 56 perioperatively 56 confounding variables 56 nondemented 56 nonvertebral fractures 56 coronary calcification 56 triglyceride concentration 56 LV ejection fraction 56 psychiatric outpatients 56 comorbid diagnoses 56 acute subacute 56 pulmonary capillary wedge 56 receiving Vectibix monotherapy 56 cortical atrophy 56 diabetes mellitus hypertension 56 thiopurine 56 bioavailable testosterone 56 artery stenosis 56 isolated systolic hypertension 56 International Prognostic Scoring 56 serum folate concentrations 56 Aortic stenosis 56 Crohn Disease Activity 56 Multivariate analysis 56 pT2 56 inhospital 56 hydroxyvitamin D concentrations 56 Adjuvant chemotherapy 56 DAS# scores 56 Subgroup analyzes 56 myocardial infarctions MIs 56 laboratory abnormalities 56 Kaplan Meier curves 56 creatine kinase MB 56 nonobstructive 56 median survivals 56 multivariate Cox 56 Montgomery Åsberg Depression 56 ALT elevations 56 bronchopulmonary dysplasia BPD 56 familial clustering 56 CI -#.# 56 carotid plaque 56 acute leukemias 56 interrater reliability 56 β blockers 56 Preoperatively 56 nmol l 56 postinjury 56 PASI scores 56 Subclinical hypothyroidism 56 WOMAC pain 56 VTEs 56 macrovascular disease 56 CIN2 + 56 intima media thickness 56 perioperative morbidity 56 fasting insulin 56 affective psychoses 56 Y BOCS 56 lymphocytosis 56 CIN3 56 p = .# [002] 56 completely resected 56 multivariate regression analysis 56 nonfatal myocardial infarction MI 56 univariate 56 mmHg diastolic 56 inflammatory rheumatic 56 lipid lowering agents 56 renal cell carcinomas 56 multivariable Cox 55 hydroxyvitamin D levels 55 TEAEs 55 socioeconomic deprivation 55 Symptom severity 55 baseline LDH 55 tertile 55 prognostic factors 55 retrospective cohort 55 serum ALT 55 PSA nadir 55 Thyroid nodules 55 generalized epilepsy 55 postoperative atrial fibrillation 55 SUVmax 55 baseline CD4 55 atheroma volume 55 serum homocysteine 55 TURBT 55 urine albumin 55 BSIs 55 monoclonal gammopathy 55 thromboembolic 55 neurocognitive impairment 55 MS DRGs 55 SLNB 55 glycosylated hemoglobin levels 55 generalized estimating 55 Sociodemographic 55 acute myocardial infarction MI 55 atherothrombosis 55 elevated hsCRP 55 nonoperative treatment 55 leukocyte counts 55 glycosylated hemoglobin HbA1c 55 extensive metabolizers 55 onset diabetes mellitus 55 Heritability 55 hormone receptor negative 55 radical prostatectomy RP 55 premorbid 55 SRBD 55 atherothrombotic disease 55 Renal dysfunction 55 triacylglycerol concentrations 55 salivary cortisol 55 recurrent acute pancreatitis 55 nonischemic cardiomyopathy 55 hip resurfacing arthroplasty 55 recurrent UTI 55 Venous thromboembolism 55 Chronic ITP 55 subclinical hyperthyroidism 55 meta regression 55 empyema 55 carotid bruit 55 preeclamptic 55 myocardial infarctions 55 stratifying 55 metabolic dysregulation 55 elevated ALT 55 thyroid carcinoma 55 HSCT 55 C diff infections 55 T1DM 55 lower extremity amputation 55 abnormal lipid 55 hyperglycaemia 55 Subgroup analysis 55 left ventricular diastolic 55 subtrochanteric 55 QRS duration 55 Cockcroft Gault 55 serum bilirubin 55 IQR 55 invasive lobular 55 alanine aminotransferase 55 relapsed MM 55 dose Iluvien 55 DAS# [002] 55 elevated CRP 55 euthymic 55 Skin sterol 55 thrombocytopenic 55 serum ferritin 55 liver histology 55 glycated hemoglobin 55 cardio respiratory fitness 55 FDA defined valvulopathy 55 T1a 55 sternal wound infections 55 aminotransferase levels 55 Index CDAI 55 statistically significant correlation 55 incidentalomas 55 fragility fracture 55 Coronary artery bypass graft 55 gestational hypertension 55 μg liter 55 clinicopathological 55 Lumbar spine 55 transferrin saturation 55 confounder 55 Insulin sensitivity 55 MGUS 55 BPS IC 55 mammographic breast density 55 elevated IOP 55 mammographic density 55 CLBP 55 homocysteine concentrations 55 unstable angina pectoris 55 atrophic gastritis 55 antibody titer 55 preoperative diagnosis 55 clinically evaluable 55 interindividual variability 55 bronchioloalveolar carcinoma 55 incomplete revascularization 55 microscopic colitis 55 suicide attempters 55 HF hospitalization 55 conditional logistic regression 55 grade astrocytomas 55 puerperal psychosis 55 pre eclamptic 55 revascularization procedures 55 nonacute 55 genotypic resistance 55 BMPR2 55 Febrile neutropenia 55 mild renal insufficiency 55 Juvenile Idiopathic Arthritis 55 prespecified secondary 55 APOE e4 55 Generalized anxiety disorder 55 morbidity mortality 55 stepwise logistic regression 55 lymph node involvement 55 Medication adherence 55 systolic BP 55 -#.# log# 55 hormone receptor status 55 T2 lesions 55 interquartile range 55 socioeconomic variables 55 colon resection 55 perinatal outcomes 55 nonobstructive CAD 55 PLX STROKE targeting 55 Synovial sarcoma 55 Brief Psychiatric 55 ICD implantation 55 elevated LDL cholesterol 55 NATRECOR R 55 aged ≥ 55 explanatory variables 55 LVEF 55 pyelonephritis 55 Disease Activity 55 tHcy 55 clinico pathological 55 carotid artery narrowing 55 asymptomatic carotid stenosis 55 depressive symptom 54 hyperinsulinemic 54 sociodemographics 54 UPDRS motor 54 systolic diastolic 54 Calcium intake 54 Rating Scale BPRS 54 transrectal ultrasound guided 54 baseline A1C 54 serum phosphate 54 demographic variables 54 periprocedural 54 familial aggregation 54 waist circumferences 54 hsCRP levels 54 asthma exacerbation 54 glomerular filtration rate 54 fractional anisotropy 54 guideline concordant 54 HRCT 54 pulsatility index 54 Postoperative complications 54 Kaplan Meier curve 54 BLLs 54 supratentorial 54 biochemical relapse 54 anemia hemoglobin 54 neurocognitive deficits 54 severe periodontitis 54 metabolic derangement 54 co morbidities 54 telomere lengths 54 EoE 54 prospectively stratified 54 Wisconsin Sleep Cohort 54 EuroSCORE 54 lactate dehydrogenase LDH 54 serum phosphate levels 54 cerebrovascular accident 54 dyslipidaemia 54 seropositivity 54 portal vein thrombosis 54 Poisson regression 54 visceral adiposity 54 folate intakes 54 mucinous 54 bladder carcinoma 54 Polycythemia vera 54 pretransplant 54 Arch Intern Med 54 erythema nodosum 54 nadroparin 54 rs# [004] 54 aortic atherosclerosis 54 juvenile idiopathic arthritis JIA 54 serum calcium levels 54 ß blockers 54 lymphocyte count 54 colorectal liver metastases 54 somatic symptoms 54 psychosocial functioning 54 differential gene expression 54 peripartum 54 Chronic pancreatitis 54 coronary revascularization procedures 54 CC genotype 54 Genetic variants 54 lumbar spine BMD 54 hepatic fibrosis 54 Cystatin C 54 BMI percentiles 54 Kaplan Meier analysis 54 thromboembolic complications 54 Apgar scores 54 symptomatic intracerebral hemorrhage 54 #OHD levels 54 normal birthweight 54 Kaplan Meier estimate 54 PCNSL 54 cirrhotic patients 54 CTEPH 54 prepregnancy BMI 54 MTHFD1L gene 54 HYVET 54 Postnatal depression 54 hematologic toxicity 54 intracranial hemorrhage ICH 54 serum triglycerides 54 mm Hg diastolic 54 LVNC 54 CCyR 54 adverse perinatal 54 HbA 1c 54 underwent resection 54 karyotypes 54 ipsilateral stroke 54 symptomatic VTE 54 multiple linear regression 54 Visual Analogue Scale VAS 54 QoL 54 de ath 54 APOE ε4 54 lobular cancer 54 highest quintile 54 hypoperfusion 54 serum parathyroid hormone 54 Vertebral fractures 54 intraobserver 54 plasma homocysteine 54 treat NNT 54 elevated bilirubin 54 dichotomized 54 umol L 54 undergo prostate biopsy 54 oxycodone CR 54 inversely associated 54 POAG 54 fibroids endometriosis 54 nephron sparing surgery 54 cerebral vasospasm 54 serum cortisol 54 tryptophan depletion 54 Fasting plasma glucose 54 ABCB1 54 cardioembolic 54 diabetes hypertension hyperlipidemia 54 precancerous cervical 54 lymphadenectomy 54 cTnT levels 54 estimated GFR 54 kg m² 54 prevalences 54 Fibromyalgia Impact Questionnaire 54 waist circumference measurements 54 undergoing CABG 54 locoregional recurrence 54 recurrent DVT 54 Proteinuria 54 variceal bleeding 54 recurrent atrial fibrillation 54 prognostic indicators 54 severe exacerbations 54 moderate renal impairment 54 serum albumin 54 multivariable logistic regression 54 SSc 54 Health Assessment Questionnaire 54 nonfatal myocardial infarction 54 potential confounding variables 54 mineral density 54 revascularizations 54 Hemoglobin A1c 54 artery calcification 54 nulliparous women 54 Serum calcium 54 heterozygotes 54 Scale EDSS 54 bicuspid aortic valves 54 Morbid obesity 54 severe mitral regurgitation 54 fasting serum 54 MRSA colonization 54 OSDI 54 alexithymia 54 cardiopulmonary diseases 54 neurologic sequelae 54 carotid artery blockage 54 thromboprophylaxis 54 acetabular fractures 54 chlamydial infection 54 serum testosterone 54 cerebrovascular events 54 nonsignificant difference 54 chronicity 54 #.#ng/ml 54 CYP#D# genotype 54 chronic periodontitis 54 untreated OSA 54 undergoing radical prostatectomy 54 HbA1c levels 54 distal radial fractures 54 antioxidant supplementation 54 gene APOE 54 fragility fractures 54 diastolic blood pressures 54 LVSD 54 leucopenia 54 nodal metastasis 54 ± SD 54 recurrent ischemia 54 hepatocellular carcinomas 54 extrapyramidal symptoms 54 phytoestrogen intake 54 internalizing disorders 54 rho = 54 abnormal lipids 54 carbohydrate intolerance 54 systolic function 54 perinatal complications 54 coronary revascularizations 54 seminomas 54 Heavy menstrual bleeding 54 preterm neonates 54 atherothrombotic 54 testicular tumors 54 WOMAC scores 54 covariates 54 unfavorable prognostic 54 nondiabetics 54 IRLS score 54 apolipoprotein B 54 achieved ACR# 54 microbiologically evaluable 54 subscore 54 endometrial thickness 54 BMD measurements 53 BEXXAR Therapeutic Regimen 53 silent myocardial ischemia 53 pancreatic fistula 53 subscale scores 53 MACCE 53 Ischemic heart 53 NYHA functional class 53 bivariate analysis 53 Socio demographic 53 preoperatively 53 Ebstein anomaly 53 Major depressive disorder 53 neovascular glaucoma 53 Depressive symptoms 53 Negative Symptoms 53 acute rheumatic fever 53 microvessel density 53 APOC3 53 ADCS ADL 53 transaminase elevations 53 transfusion syndrome 53 serum magnesium 53 decompensated cirrhosis 53 endocrinologic 53 Comorbidities 53 atherosclerotic renal artery stenosis 53 Tasigna prolongs 53 serum leptin 53 INVEGA ® 53 rheumatic disorders 53 hyperoxaluria 53 visceral metastases 53 mean baseline A1C 53 anthropometric measures 53 low birthweight infants 53 overt hypothyroidism 53 resected pancreatic cancer 53 ventilation perfusion 53 chronic hepatitis cirrhosis 53 syndromic 53 colorectal cancer incidence 53 receiving ISENTRESS 53 nonadherent 53 placebo fluoxetine 53 dyssynchrony 53 Triglyceride levels 53 metabolic syndrome MetS 53 recurrent miscarriage 53 neurocognitive function 53 ejection fractions 53 diagnosing ADHD 53 peak VO2 53 PCa 53 oxygen desaturation 53 indicates cardio circulatory 53 thyroid nodules 53 Preterm infants 53 serum BDNF 53 indolent lymphomas 53 euthyroid 53 cytogenetic abnormalities 53 cryptogenic 53 invasive ductal breast cancer 53 anastomotic leak 53 Main Outcome Measure 53 nephrolithiasis 53 nonmetastatic 53 C. trachomatis 53 intact parathyroid hormone 53 ischemia driven 53 specific antigen PSA 53 sinus node dysfunction 53 efficacy evaluable 53 intensive statin therapy 53 pancreatic adenocarcinoma 53 CrCl 53 reinfarction 53 CSF biomarkers 53 serum retinol 53 ECOG PS 53 bowel resection 53 Preterm delivery 53 cytogenic 53 maternal morbidity 53 baseline serum creatinine 53 elevated homocysteine 53 preterm deliveries 53 gastroduodenal 53 HBeAg seroconversion 53 tipranavir r 53 anemia neutropenia 53 LS BMD 53 Adenomas 53 AMOR IPAT 53 μg dL 53 Coronary artery calcification 53 tibiofemoral 53 dietary calcium intake 53 intracranial stenosis 53 convulsive disorders 53 neurodevelopmental outcome 53 Sarcopenia 53 HOXB# 53 atheromatous 53 CHADS 53 multiple logistic regression 53 humoral responses 53 AGGRASTAT R tirofiban hydrochloride 53 perimenopausal women 53 intracerebral haemorrhage 53 radiotherapy RT 53 angiographic outcomes 53 microbleeds 53 placenta accreta 53 K ras mutations 53 neutropaenia 53 Fasting blood glucose 53 carotid atherosclerosis 53 BMI waist circumference 53 TAVR 53 Osteopenia 53 oncological outcomes 53 Low birthweight 53 % CI #.#-#.# [005] 53 dose ionizing radiation 53 confidence interval CI 53 Asymptomatic 53 comorbid psychiatric 53 paternal discrepancy 53 serum concentrations 53 vertebral fracture 53 Vitamin D insufficiency 53 leiomyomas 53 noncardiovascular 53 experienced virologic failure 53 coronary artery calcification 53 fasting plasma 53 prognostically 53 pharmacologic treatments 53 gadolinium enhanced 53 Homocysteine levels 53 ICD shocks 53 lipid elevations 53 acromegalic patients 53 hormonal abnormalities 53 hyperbilirubinemia 53 serum estradiol 53 cytoreductive nephrectomy 53 hemoglobin Hb 53 arterial calcification 53 proton MR spectroscopy 53 mIU L 53 hydroxyvitamin D 53 #.#mmol L [002] 53 fasting glucose levels 53 NAMCS 53 dose statin therapy 53 silent ischemia 53 morphometric vertebral fractures 53 Neuropsychiatric Inventory 53 plasma folate 53 adjuvant systemic 53 low birthweights 53 distal colon cancer 53 2 diabetes T2D 53 CDAI 53 schizophrenia schizoaffective disorder 53 deCODE BreastCancer TM 53 GI bleeding 53 BRCA2 mutation carriers 53 covariance 53 colorectal neoplasms 53 -#.# ± [002] 53 % CI #.#-#.# [004] 53 hypercoagulable 53 Endothelial dysfunction 53 ADCS CGIC 53 biliary tract cancer 53 Telomere length 53 PCWP 53 nontraumatic 53 x ULN 53 ventricular dysfunction 53 geriatric syndromes 53 pathologic diagnosis 53 radical nephrectomy 53 mITT 53 intermittent exotropia 53 obstructive coronary 53 progression TTP 53 Mantel Haenszel 53 CPAP adherence 53 Suicidal ideation 53 impaired cognition 53 hallux valgus 53 CFQ R 53 socioeconomic characteristics 53 neutrophil counts 53 underwent liver transplantation 53 symptomatic intracranial hemorrhage

Back to home page